Skip to main content
. 2021 Oct 22;11:751777. doi: 10.3389/fonc.2021.751777

Table 6.

Survival analysis by duration of MVR, tumor burden or splenomegaly in the MVR group.

OS rate (%) P value
1-year 3-year 5-year
MVR status <0.001
 ≤1y (n=123) 57.2 10.9 6 < 0.001
 1-2y (n=190) 70.6 16.0 13.7 0.024
 >2y (n=229) 88.2 25.2 21.8 reference
Tumor burden 0.002
 Within up-to-7 77.0 20.5 16.9
 Beyond up-to-7 65.5 12.4 8.3
Splenomegaly 0.034
 No 76.3 20.9 16.1
 Yes 70.7 13.2 13.2